Principal Investigators




    Contact information of lead PI



    Title of project or programme

    Developing, evaluating, and disseminating new methods and technologies to advance Parkinson disease research

    Source of funding information


    Total sum awarded (Euro)

    € 704,122.94

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Parkinson's disease & PD-related disorders


    Parkinson Disease, Cellular Phone, models and simulation, Signs and Symptoms, Plague

    Research Abstract

    ? DESCRIPTION (provided by applicant): Clinical drug development costs have increased ten-fold over a decade; however, the productivity of the industry continues to decline. For neurodegenerative conditions like Parkinson disease, clinical trials are increasingly large, long, and expensive, yet trials continue to be plagued by high failure rates. Novel approaches are, therefore, required. New research methods including disease modeling and simulation, and new technologies that enable remote participation in research studies and objective measurement of disease, such as smartphones and sensors, can help evaluate therapeutics more efficiently. However, these methods and technologies have had limited application in Parkinson disease studies to date. A “”laboratory”” to develop, evaluate and disseminate these and other new approaches to research can help advance the field. In this application, we outline the development of the administrative infrastructure, collaborative partnerships, and research capabilities necessary to construct such a laboratory. This proposal addresses many of the recommendations outlined in NINDS’s “”Parkinson’s Disease 2014: Advancing Research, Improving Lives,”” and will develop into a valuable Morris K. Udall Center of Excellence to serve as a unique resource for other Udall Centers and the greater Parkinson disease community.

    Lay Summary

    PUBLIC HEALTH RELEVANCE: This exploratory grant will develop, evaluate and disseminate new methods and technologies to advance therapeutic development for Parkinson disease. Our vision is that these new approaches, which include simulation models, remote assessments, and objective measures of disease, will modernize Parkinson disease clinical research and enable anyone anywhere with Parkinson disease to engage in research, benefit from therapeutic advances, and receive care.

    Further information available at:

Types: Investments > €500k
Member States: United States of America
Diseases: Parkinson's disease & PD-related disorders
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF